Targeting Post-Transplant Minimal Residual CD19+ ALL with Genetically-

$292,514P01FY2006CANIH

Beckman Research Institute/City Of Hope, Duarte CA

Investigators

Laurence J.n. Coopercontact

Linked publications, trials & patents

Paper 37301631 Paper 35534000 Paper 34153501 Paper 26680375 Paper 26457961 Paper 26330164 Paper 25838392 Paper 25412505 Paper 25366031 Paper 25243629 Paper 24714354 Paper 24488441 Paper 24329797 Paper 24159171 Paper 24030378 Paper 24030258 Paper 23927520 Paper 23832663 Paper 23755242 Paper 23583827 Paper 23480492 Paper 23377665 Paper 23308079 Paper 23303282 Paper 23243288 Paper 23183426 Paper 23152525 Paper 23151215 Paper 23090116 Paper 23090078 Paper 23078784 Paper 23073267 Paper 23034279 Paper 23000644 Paper 22906206 Paper 22904105 Paper 22677229 Paper 22611160 Paper 22402037 Paper 21976673 Paper 21843052 Paper 21821714 Paper 21801706 Paper 21763253 Paper 21719601 Paper 21699453 Paper 21672050 Paper 21664286 Paper 21653320 Paper 21652685 Paper 21557459 Paper 21527558 Paper 21385932 Paper 21358679 Paper 21338704 Paper 21281228 Paper 21191005 Paper 21151180 Paper 21123821 Paper 21088258 Paper 21047977 Paper 20960189 Paper 20876852 Paper 20861916 Paper 20656930 Paper 20639760 Paper 20564108 Paper 20551836 Paper 20471051 Paper 20457264 Paper 20353830 Paper 20350626 Paper 20304086 Paper 20197101 Paper 20089962 Paper 20070620 Paper 20053337 Paper 19969118 Paper 19965688 Paper 19959108 Paper 19822300 Trial NCT01476839 Trial NCT00712634 Trial NCT00695409 Trial NCT00577278 Trial NCT00562978 Trial NCT00544570 Patent 9974854 Patent 9931395 Patent 9657105 Patent 9453227 Patent 9090673 Patent 8580276 Patent 8227191 Patent 7387782 Patent 7163685 Patent 6562345 Patent 6410319 Patent 6133433 Patent 5075213

View original record on NIH RePORTER →